CB Therapeutics

Recent Finacing

Series A

Recent Raise

Undisclosed

CB Therapeutics operates a San Diego-based synthetic biology and cellular agriculture platform engineering microorganisms to biosynthesize tryptamines, cannabinoids, and novel analogs for therapeutic and nutraceutical research and scaled manufacturing.

Founded 2015

California, United States

11-50

Private

cbthera.com

Highlights

Focus Areas

Biotechnology

Cannabis

Therapeutics

Recent Investors

Financials

$7.5M

Total Raised

2

Funding rounds

1

Investor

Team

Upgrade to view the team

See the team members at CB Therapeutics.